Literature DB >> 24608302

Synchronous colorectal carcinoma: a risk factor in colorectal cancer surgery.

Nicoline J van Leersum1, Arend G Aalbers, Heleen S Snijders, Daniel Henneman, Michel W Wouters, Rob A Tollenaar, Eric Hans Eddes.   

Abstract

BACKGROUND: Synchronous colorectal carcinoma occurs in 1% to 8% of cases. There are little data on the impact of synchronous colorectal cancer on surgical treatment and short-term postoperative outcomes.
OBJECTIVE: The purpose of this work was to evaluate clinical characteristics and treatment patterns of synchronous colorectal carcinoma and their influence on short-term postoperative outcomes in comparison with solitary colorectal carcinoma.
DESIGN: This was a population-based observational study. Patient and tumor characteristics, treatment patterns, and postoperative outcomes are described for patients with a solitary and synchronous colorectal carcinoma separately. Multivariable logistic regression analysis was used to analyze the association between synchronous colorectal carcinoma and postoperative complications in comparison with a solitary colorectal carcinoma. SETTINGS: The study included in-hospital registration for the Dutch Surgical Colorectal Audit. PATIENTS: Patients were those with primary colorectal carcinoma from 2009 to 2011. MAIN OUTCOME MEASURES: Severe postoperative complications, reinterventions, and 30-day mortality were measured.
RESULTS: Of 25,413 patients with colorectal cancer, 884 (3.5%) had synchronous colorectal tumors. Patients with synchronous colorectal carcinoma were older and more often of male sex compared with patients with solitary colorectal carcinoma. In ≥ 35% of cases, an extended surgical procedure was conducted (n = 310). In multivariable logistic regression analysis, synchronous colorectal carcinoma was associated with a higher risk of severe postoperative complications (OR, 1.40; 95% CI, 1.20-1.63) and reinterventions (OR, 1.37; 95% CI, 1.14-1.65) compared with solitary colorectal carcinoma but not with higher 30-day mortality (OR, 1.34; 95% CI, 0.96-1.88). LIMITATIONS: This study was limited by the data being self-reported. Case-mix adjustment was limited to information available in the data set, and no long-term outcome data were available.
CONCLUSIONS: Synchronous colorectal carcinomas are prevalent in 3.5% of patients and require a different treatment strategy in comparison with solitary colorectal carcinoma. Postoperative outcomes are unfavorable, most likely because of extensive surgery.

Entities:  

Mesh:

Year:  2014        PMID: 24608302     DOI: 10.1097/DCR.0000000000000068

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  16 in total

Review 1.  Synchronous triple colorectal carcinoma: a case report and review of literature.

Authors:  Ji Cheng; Xinghua Liu; Xiaoming Shuai; Meizhou Deng; Jinbo Gao; Kaixiong Tao
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  LncRNA, a novel target biomolecule, is involved in the progression of colorectal cancer.

Authors:  Weihong Sun; Shaoshao Ren; Ran Li; Qingshan Zhang; Haiping Song
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

3.  Synchronous trifocal colorectal cancer.

Authors:  Petros Charalampoudis; Georgios C Sotiropoulos; Stylianos Kykalos; Paraskevas Stamopoulos; Gregory Kouraklis
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-10

4.  Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands.

Authors:  Michael P M de Neree Tot Babberich; Nina C A Vermeer; Michel W J M Wouters; Wilhelmina M U van Grevenstein; Koen C M J Peeters; Evelien Dekker; Pieter J Tanis
Journal:  JAMA Surg       Date:  2018-12-19       Impact factor: 14.766

5.  Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery.

Authors:  Geert A Simkens; Vic J Verwaal; Valery E Lemmens; Harm J Rutten; Ignace H de Hingh
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

6.  Clinical characteristics of synchronous colorectal cancers in Japan.

Authors:  Takaharu Kato; Sergio Alonso; Yuta Muto; Hiroshi Noda; Yasuyuki Miyakura; Koichi Suzuki; Shingo Tsujinaka; Masaaki Saito; Manuel Perucho; Toshiki Rikiyama
Journal:  World J Surg Oncol       Date:  2016-10-24       Impact factor: 2.754

7.  Clinicopathological features and surgical options for synchronous colorectal cancer.

Authors:  Byoung Chul Lee; Chang Sik Yu; Jihun Kim; Jong Lyul Lee; Chan Wook Kim; Yong Sik Yoon; In Ja Park; Seok-Byung Lim; Jin Cheon Kim
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

8.  Prospective Analysis of More than 1,000 Patients with Rectal Carcinoma: Are There Gender-Related Differences?

Authors:  Markus Kleemann; Claudia Benecke; Diana Helfrich; Hans-Peter Bruch; Tobias Keck; Tilman Laubert
Journal:  Viszeralmedizin       Date:  2014-04

9.  Laparoscopy-assisted versus open surgery for multiple colorectal cancers with two anastomoses: a cohort study.

Authors:  Hiroaki Nozawa; Soichiro Ishihara; Koji Murono; Koji Yasuda; Kensuke Otani; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Keisuke Hata; Kazushige Kawai; Hironori Yamaguchi; Toshiaki Watanabe
Journal:  Springerplus       Date:  2016-03-08

Review 10.  Simultaneous curative resection of double colorectal carcinoma with synchronous bilobar liver metastases.

Authors:  Emilio De Raffele; Mariateresa Mirarchi; Dajana Cuicchi; Ferdinando Lecce; Claudio Ricci; Riccardo Casadei; Bruno Cola; Francesco Minni
Journal:  World J Gastrointest Oncol       Date:  2018-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.